/Pfizer%20Inc_%20NY%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Valued at a market cap of $152.2 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company dedicated to advancing healthcare through discovering, developing, manufacturing, and distributing innovative medicines and vaccines. The company's extensive portfolio encompasses products like Eliquis, Comirnaty, and Paxlovid, addressing worldwide health challenges. The New York-based company is expected to announce its fiscal Q4 earnings results before the market opens on Tuesday, Feb. 4.
Ahead of this event, analysts expect the drugmaker to report a profit of $0.48 per share, up significantly from $0.10 per share in the year-ago quarter. The company has surpassed Wall Street's earnings estimates in the last four quarters. In Q3, PFE exceeded the consensus EPS estimate by 65.6%.